Rudolf Wagner: Digital Health Thought Leader
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
How are the regulatory landscape and market compliance practiced when determining the safety of AI software that would impact healthcare globally? Digital Health Thought Leader, Rudolf Wagner, tells us how.
To connect with Rudolf, connect with him on LinkedIn here.
Key Takeaways:
1. Germany has a two-fold regulatory environment for software as a medical device. The first is those who produce AI for clinical use, and then what happens in the hospital.
2. When a major situation occurs, there is a change to a more strict regulation.
3. Software is measured in a matter of days and not years and the current regulatory environment needs to get ahead of the market or allow people to be on their own.
adbl_web_anon_alc_button_suppression_c
No reviews yet